NASDAQ:WCRX - Warner Chilcott Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Warner Chilcott (NASDAQ:WCRX)

Warner Chilcott logoWarner Chilcott Public Limited Company is a specialty pharmaceutical company. The Company is focused on the women's healthcare, gastroenterology, dermatology and urology segments of the branded pharmaceuticals market, primarily in North America. The Company's hormonal contraceptive product offerings include LOESTRIN 24 FE (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), the branded product in the United States hormonal contraception market, and LO LOESTRIN FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets), its new oral contraceptive product, launched in January 2011, that offers women the lowest dosage of estrogen of any oral contraceptive available in the United States market. In October 2013, Actavis Inc acquired the entire share capital of Warner Chilcott PLC.

Receive WCRX News and Ratings via Email

Sign-up to receive the latest news and ratings for WCRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Warner Chilcott (NASDAQ:WCRX) Frequently Asked Questions

What is Warner Chilcott's stock symbol?

Warner Chilcott trades on the NASDAQ under the ticker symbol "WCRX."

Who are some of Warner Chilcott's key competitors?

Has Warner Chilcott been receiving favorable news coverage?

Press coverage about WCRX stock has been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Warner Chilcott earned a news impact score of 0.16 on Accern's scale. They also assigned news articles about the specialty pharmaceutical company an impact score of 44.54 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

How do I buy shares of Warner Chilcott?

Shares of WCRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Warner Chilcott?

Warner Chilcott's mailing address is Grand Canal Square, DUBLIN,, Ireland. The specialty pharmaceutical company can be reached via phone at +353-1-8972000.

MarketBeat Community Rating for Warner Chilcott (WCRX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  144 (Vote Outperform)
Underperform Votes:  118 (Vote Underperform)
Total Votes:  262
MarketBeat's community ratings are surveys of what our community members think about Warner Chilcott and other stocks. Vote "Outperform" if you believe WCRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WCRX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Warner Chilcott (NASDAQ:WCRX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/23/2016 forward)


Warner Chilcott (NASDAQ:WCRX) Earnings History and Estimates Chart

Earnings by Quarter for Warner Chilcott (NASDAQ:WCRX)

Warner Chilcott (NASDAQ WCRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2013Q2 2013$0.84$0.92$598.23 million$613.00 millionViewN/AView Earnings Details
5/10/2013Q1 2013$0.85$0.45$588.06 million$593.00 millionViewN/AView Earnings Details
2/22/2013Q4 2012$0.73$0.50$565.21 million$612.00 millionViewN/AView Earnings Details
11/9/2012Q312$0.77$0.99$595.96 million$606.00 millionViewN/AView Earnings Details
8/3/2012$0.79$1.03ViewN/AView Earnings Details
5/4/2012$0.93$1.16ViewN/AView Earnings Details
2/24/2012$0.90$0.95ViewN/AView Earnings Details
11/4/2011$0.90$0.89ViewN/AView Earnings Details
8/5/2011$0.89$0.93ViewN/AView Earnings Details
5/6/2011$0.82$1.04ViewN/AView Earnings Details
2/25/2011$0.74$0.81ViewN/AView Earnings Details
11/8/2010Q3 2010$0.82$0.88ViewN/AView Earnings Details
8/6/2010Q2 2010$0.81$0.96ViewN/AView Earnings Details
5/7/2010Q1 2010$0.85$0.88ViewN/AView Earnings Details
3/1/2010Q4 2009$0.57$0.70ViewN/AView Earnings Details
11/9/2009Q3 2009$0.42$0.41ViewN/AView Earnings Details
8/7/2009Q2 2009$0.39$0.44ViewN/AView Earnings Details
5/11/2009Q1 2009$0.39$0.38ViewN/AView Earnings Details
2/27/2009Q4 2008$0.37$0.40ViewN/AView Earnings Details
11/10/2008Q3 2008$0.33$0.39ViewN/AView Earnings Details
8/8/2008Q2 2008$0.32$0.33ViewN/AView Earnings Details
5/9/2008Q1 2008$0.28$0.33ViewN/AView Earnings Details
2/29/2008Q4 2007$0.26$0.30ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Warner Chilcott (NASDAQ:WCRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Warner Chilcott (NASDAQ WCRX) Insider Trading and Institutional Ownership History

Insider Trading History for Warner Chilcott (NASDAQ:WCRX)

Warner Chilcott (NASDAQ WCRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


Warner Chilcott (NASDAQ WCRX) News Headlines

Warner Chilcott (WCRX) and Pfizer (PFE) Financial SurveyWarner Chilcott (WCRX) and Pfizer (PFE) Financial Survey - February 19 at 7:22 PM
Critical Review: Warner Chilcott (WCRX) versus Celgene (CELG)Critical Review: Warner Chilcott (WCRX) versus Celgene (CELG) - February 10 at 7:24 AM
Analyzing Warner Chilcott Plc (WCRX) and Eyegate Pharmaceuticals (EYEG)Analyzing Warner Chilcott Plc (WCRX) and Eyegate Pharmaceuticals (EYEG) - October 27 at 7:30 PM
Financial Comparison: Akorn (AKRX) and Warner Chilcott Plc (WCRX)Financial Comparison: Akorn (AKRX) and Warner Chilcott Plc (WCRX) - October 22 at 4:26 PM
$54 Million Settlement Resolving Whistleblower Claims Against CareCore National LLC Announced$54 Million Settlement Resolving Whistleblower Claims Against CareCore National LLC Announced - May 13 at 2:54 AM
BRIEF-Allergan announces tender offers by certain subsidiariesBRIEF-Allergan announces tender offers by certain subsidiaries - May 12 at 4:26 AM

SEC Filings

Warner Chilcott (NASDAQ:WCRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Warner Chilcott (NASDAQ:WCRX) Income Statement, Balance Sheet and Cash Flow Statement


Warner Chilcott (NASDAQ WCRX) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.